Related references
Note: Only part of the references are listed.Parenteral nutrition dysregulates bile salt homeostasis in a rat model of parenteral nutrition-associated liver disease
Kiran V. K. Koelfat et al.
CLINICAL NUTRITION (2017)
P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis
Yong-Tao Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
AMPKα1 overexpression alleviates the hepatocyte model of nonalcoholic fatty liver disease via inactivating p38MAPK pathway
Hong-Ai Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure
Annika Mutanen et al.
JOURNAL OF HEPATOLOGY (2014)
Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice
Li-Hua Zhu et al.
JOURNAL OF HEPATOLOGY (2014)
Incidence, Prevention, and Treatment of Parenteral Nutrition-Associated Cholestasis and Intestinal Failure-Associated Liver Disease in Infants and Children: A Systematic Review
Giuseppe Lauriti et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2014)
Liver-Specific p38α Deficiency Causes Reduced Cell Growth and Cytokinesis Failure During Chronic Biliary Cirrhosis in Mice
Ana M. Tormos et al.
HEPATOLOGY (2013)
Post-transcriptional activation of PPM alpha by KLF6 in hepatic steatosis
Lars P. Bechmann et al.
JOURNAL OF HEPATOLOGY (2013)
Parenteral Plant Sterols and Intestinal Failure-associated Liver Disease in Neonates
Annika Kurvinen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
Integrin-Dependent Akt1 Activation Regulates PGC-1 Expression and Fatty Acid Oxidation
Craig C. Beeson et al.
JOURNAL OF VASCULAR RESEARCH (2012)
Overexpression of Cholesterol 7α-Hydroxylase Promotes Hepatic Bile Acid Synthesis and Secretion and Maintains Cholesterol Homeostasis
Tiangang Li et al.
HEPATOLOGY (2011)
The Prevention and Treatment of Intestinal Failure-associated Liver Disease in Neonates and Children
Deepika Nehra et al.
SURGICAL CLINICS OF NORTH AMERICA (2011)
Transgenic Expression of Cholesterol 7α-Hydroxylase in the Liver Prevents High-Fat Diet Induced Obesity and Insulin Resistance in Mice
Tiangang Li et al.
HEPATOLOGY (2010)
Recent advances in the management of intestinal failure-associated liver disease
Alan Wiles et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2009)
p38MAPK: stress responses from molecular mechanisms to therapeutics
Lydia R. Coulthard et al.
TRENDS IN MOLECULAR MEDICINE (2009)
p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin-induced liver failure
Jan Heinrichsdorff et al.
EMBO REPORTS (2008)
Evidence for a Role of Epithelial Mesenchymal Transition During Pathogenesis of Fistulae in Crohn's Disease
Frauke Bataille et al.
INFLAMMATORY BOWEL DISEASES (2008)
Antagonistic control of cell fates by JNK and p38-MAPK signaling
T. Wada et al.
CELL DEATH AND DIFFERENTIATION (2008)
p38α -: A suppressor of cell proliferation and tumorigenesis
Lijian Hui et al.
CELL CYCLE (2007)
Intestinal failure-associated liver disease: Management and treatment strategies past, present, and future
Beth A. Carter et al.
SEMINARS IN LIVER DISEASE (2007)
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway
Lijian Hui et al.
NATURE GENETICS (2007)
p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis
Yan Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes
Qu Fan Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CCAAT/enhancer-binding protein α mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase
Liping Qiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis
H Malhi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARα and PGC-1
WJ Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
p38 mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis
WH Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Resistin-like molecule β activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet
A Kushiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selective activation of mitogen-activated protein (MAP) kinase kinase 3 and p38α MAP kinase is essential for cyclic AMP-dependent UCP1 expression in adipocytes
J Robidoux et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
PGC-1α activates CYP7A1 and bile acid biosynthesis
DJ Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice
RJ Gum et al.
MOLECULAR ENDOCRINOLOGY (2003)
p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor α -: A potential role in the cardiac metabolic stress response
PM Barger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1
P Puigserver et al.
MOLECULAR CELL (2001)
Down-regulation of cholesterol 7α-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway
S Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
